SCHEMBL9967775

SCHEMBL9967775

CC(C)/C=C/c1ccc(Cl)c(Cl)c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHAT P28329 1/20 0.50
ALDH1A1 P00352 1/20 0.48
PYGL P06737 7/20 0.42
KDM4A O75164 1/20 0.41
KDM4B O94953 1/20 0.41
PTGS2 P35354 1/20 0.41
NOS3 P29474 2/20 0.40
NOS1 P29475 2/20 0.40
NOS2 P35228 2/20 0.40
GUSB P08236 1/20 0.38
KMT2A Q03164 1/20 0.38
NPSR1 Q6W5P4 1/20 0.38
NPFFR2 Q9Y5X5 1/20 0.38
MAOB P27338 1/20 0.38
GRIK1 P39086 1/20 0.38
GRIK2 Q13002 1/20 0.38
NPC1 O15118 2/20 0.38
RAB9A P51151 2/20 0.38
THRB P10828 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8956776 0.84 CHAT (0.47) CHATALDH1A1PYGLKDM4AKDM4B
SCHEMBL8956785 0.84 CHAT (0.47) CHATALDH1A1PYGLKDM4AKDM4B
SCHEMBL8956756 0.84 CHAT (0.47) CHATALDH1A1PYGLKDM4AKDM4B
SCHEMBL13597784 0.82 TRPA1 (0.41) CHATALDH1A1KMT2ANPSR1
SCHEMBL10973260 0.79 ALDH1A1 (0.64) CHATALDH1A1PYGLKDM4AKDM4B
SCHEMBL10973255 0.79 ALDH1A1 (0.64) CHATALDH1A1PYGLKDM4AKDM4B
SCHEMBL9967783 0.78 APP (0.35) CHATNPFFR2
SCHEMBL16638511 0.78 CHAT (0.33) CHATPYGLNOS3NOS1NOS2
SCHEMBL9720852 0.77 CHAT (0.67) CHATALDH1A1PYGLKDM4AKDM4B
SCHEMBL9720849 0.77 CHAT (0.67) CHATALDH1A1PYGLKDM4AKDM4B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150173359-A1 SUBSTITUTED FUSED PYRIMIDINONES AND DIHYDROPYRIMIDINONES BAYER IP GMBH (DE) 2015-06-25 US disclosed
US-20150173359-A1 SUBSTITUTED FUSED PYRIMIDINONES AND DIHYDROPYRIMIDINONES BAYER IP GMBH (DE) 2015-06-25 US disclosed
US-9006265-B2 Substituted fused pyrimidinones and dihydropyrimidinones BAYER INTELLECTUAL PROPERTY GMBH (DE) 2015-04-14 US disclosed
US-9006265-B2 Substituted fused pyrimidinones and dihydropyrimidinones BAYER INTELLECTUAL PROPERTY GMBH (DE) 2015-04-14 US disclosed
US-20120157306-A1 Substituted Fused Pyrimidinones and Dihydropyrimidinones BAYER CROPSCIENCE AG (DE) 2012-06-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150173359-A1 SUBSTITUTED FUSED PYRIMIDINONES AND DIHYDROPYRIMIDINONES DHPS, FDPS, DPYD CHAT 4726/4885ALDH1A1 333/4885PYGL 4029/4885
US-20120157306-A1 Substituted Fused Pyrimidinones and Dihydropyrimidinones DHPS, FDPS, DPYD CHAT 4726/4885ALDH1A1 333/4885PYGL 4029/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.